Skip to main content
Erschienen in: Pituitary 2/2010

01.06.2010

A heritable predisposition to pituitary tumors

verfasst von: William T. Couldwell, Lisa Cannon-Albright

Erschienen in: Pituitary | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Pituitary tumors are prevalent in the general population, with a frequency of nearly 1 in 5. The cause of most pituitary tumors remains unknown, although a genetic contribution is recognized for some. We analyzed the Utah Population Data Base (UPDB), a resource combining a computerized genealogy of the Utah population with a statewide tumor registry, to investigate familial clustering of pituitary tumors. We analyzed the genetic relationships among 741 individuals diagnosed with benign or malignant pituitary tumors who had Utah genealogy data. To test for evidence of genetic contribution to predisposition, we compared average relatedness between all pairs of individuals with pituitary tumors with the expected relatedness in this population. We also estimated relative risks (RRs) for pituitary tumors in close and distant relatives of cases by comparing observed and expected numbers of cases among relatives. Relative risks for first- and third-degree relatives were significantly elevated (RR = 2.83 and 1.63, respectively), while relative risk for second-degree relatives was not significantly different from 1.0 (RR = 0.83). The average pairwise relatedness of pituitary tumor cases was significantly higher than expected, even when close relationships were ignored. The significantly elevated risks to relatives as well as the significant excess distant relatedness observed in cases provide strong support for a genetic contribution to predisposition to pituitary tumors. Multiple high-risk pedigrees can be identified in the UPDB, and study of such pedigrees might allow identification of the gene(s) responsible for our observations. Recognizing genetic contribution to the disease may also help with counseling family members of affected individuals.
Literatur
1.
Zurück zum Zitat Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA (2008) Evidence for a heritable predisposition to death due to influenza. J Infect Dis 197:18–24CrossRefPubMed Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA (2008) Evidence for a heritable predisposition to death due to influenza. J Infect Dis 197:18–24CrossRefPubMed
2.
Zurück zum Zitat Allen-Brady K, Camp NJ, Ward JH, Cannon-Albright LA (2005) Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer 117:655–661CrossRefPubMed Allen-Brady K, Camp NJ, Ward JH, Cannon-Albright LA (2005) Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer 117:655–661CrossRefPubMed
3.
Zurück zum Zitat Arnar DO, Thorvaldsson S, Manolio TA, Thorgeirsson G, Kristjansson K, Hakonarson H, Stefansson K (2006) Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 27:708–712CrossRefPubMed Arnar DO, Thorvaldsson S, Manolio TA, Thorgeirsson G, Kristjansson K, Hakonarson H, Stefansson K (2006) Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 27:708–712CrossRefPubMed
4.
Zurück zum Zitat Arzt E, Buric R, Stelzer G, Stalla J, Sauer J, Renner U, Stalla GK (1993) Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology 132:459–467CrossRefPubMed Arzt E, Buric R, Stelzer G, Stalla J, Sauer J, Renner U, Stalla GK (1993) Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology 132:459–467CrossRefPubMed
5.
Zurück zum Zitat Arzt E, Pereda MP, Castro CP, Pagotto U, Renner U, Stalla GK (1999) Pathophysiological role of the cytokine network in the anterior pituitary gland. Front Neuroendocrinol 20:71–95CrossRefPubMed Arzt E, Pereda MP, Castro CP, Pagotto U, Renner U, Stalla GK (1999) Pathophysiological role of the cytokine network in the anterior pituitary gland. Front Neuroendocrinol 20:71–95CrossRefPubMed
6.
Zurück zum Zitat Arzt E (2001) gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathways. J Clin Invest 108:1729–1733PubMed Arzt E (2001) gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathways. J Clin Invest 108:1729–1733PubMed
7.
Zurück zum Zitat Arzt E, Chesnokova V, Stalla GK, Melmed S (2009) Pituitary adenoma growth: a model for cellular senescence and cytokine action. Cell Cycle 8:677–678PubMed Arzt E, Chesnokova V, Stalla GK, Melmed S (2009) Pituitary adenoma growth: a model for cellular senescence and cytokine action. Cell Cycle 8:677–678PubMed
8.
Zurück zum Zitat Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, Tamagno G, Cazabat L, Bours V, Brue T, Enjalbert A, Beckers A (2007) Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J Clin Endocrinol Metab 92:1952–1955CrossRefPubMed Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, Tamagno G, Cazabat L, Bours V, Brue T, Enjalbert A, Beckers A (2007) Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J Clin Endocrinol Metab 92:1952–1955CrossRefPubMed
9.
Zurück zum Zitat Bishop DT, Skolnick MH (1984) Genetic epidemiology of cancer in Utah genealogies: a prelude to the molecular genetics of common cancers. J Cell Physiol Suppl 3:63–77CrossRefPubMed Bishop DT, Skolnick MH (1984) Genetic epidemiology of cancer in Utah genealogies: a prelude to the molecular genetics of common cancers. J Cell Physiol Suppl 3:63–77CrossRefPubMed
10.
Zurück zum Zitat Burt RW, Bishop DT, Cannon LA, Dowdle MA, Lee RG, Skolnick MH (1985) Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med 312:1540–1544PubMedCrossRef Burt RW, Bishop DT, Cannon LA, Dowdle MA, Lee RG, Skolnick MH (1985) Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med 312:1540–1544PubMedCrossRef
11.
Zurück zum Zitat Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, McWhorter WP, Skolnick MH (1994) Familiality of cancer in Utah. Cancer Res 54:2378–2385PubMed Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, McWhorter WP, Skolnick MH (1994) Familiality of cancer in Utah. Cancer Res 54:2378–2385PubMed
12.
Zurück zum Zitat Cannon Albright LA, Camp NJ, Farnham JM, MacDonald J, Abtin K, Rowe KG (2003) A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg 99:637–643CrossRefPubMed Cannon Albright LA, Camp NJ, Farnham JM, MacDonald J, Abtin K, Rowe KG (2003) A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg 99:637–643CrossRefPubMed
13.
Zurück zum Zitat Cannon LA, Bishop DT, Skolnick M, Hunt SC, Lyon JL, Smart C (1982) Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1:48–69 Cannon LA, Bishop DT, Skolnick M, Hunt SC, Lyon JL, Smart C (1982) Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1:48–69
14.
Zurück zum Zitat CBTRUS (2002) Statistical report: primary brain tumors in the United States, 1995–1999. Central Brain Tumor Registry of the United States, Hinsdale CBTRUS (2002) Statistical report: primary brain tumors in the United States, 1995–1999. Central Brain Tumor Registry of the United States, Hinsdale
15.
Zurück zum Zitat Chesnokova V, Zonis S, Rubinek T, Yu R, Ben-Shlomo A, Kovacs K, Wawrowsky K, Melmed S (2007) Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Res 67:10564–10572CrossRefPubMed Chesnokova V, Zonis S, Rubinek T, Yu R, Ben-Shlomo A, Kovacs K, Wawrowsky K, Melmed S (2007) Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Res 67:10564–10572CrossRefPubMed
16.
Zurück zum Zitat Chesnokova V, Zonis S, Kovacs K, Ben-Shlomo A, Wawrowsky K, Bannykh S, Melmed S (2008) p21(Cip1) restrains pituitary tumor growth. Proc Natl Acad Sci USA 105:17498–17503CrossRefPubMed Chesnokova V, Zonis S, Kovacs K, Ben-Shlomo A, Wawrowsky K, Bannykh S, Melmed S (2008) p21(Cip1) restrains pituitary tumor growth. Proc Natl Acad Sci USA 105:17498–17503CrossRefPubMed
17.
Zurück zum Zitat Couldwell WT (2004) Transsphenoidal and transcranial surgery for pituitary adenomas. J Neurooncol 69:237–256CrossRefPubMed Couldwell WT (2004) Transsphenoidal and transcranial surgery for pituitary adenomas. J Neurooncol 69:237–256CrossRefPubMed
18.
Zurück zum Zitat Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, De Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, Wemeau JL, De Herder W, Archambeaud F, Stevenaert A, Calender A, Murat A, Cavagnini F, Beckers A (2006) Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 91:3316–3323CrossRefPubMed Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, De Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, Wemeau JL, De Herder W, Archambeaud F, Stevenaert A, Calender A, Murat A, Cavagnini F, Beckers A (2006) Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 91:3316–3323CrossRefPubMed
19.
Zurück zum Zitat Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabate MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, Wemeau JL, Caron P, Sadoul JL, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Montanana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A (2007) Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 92:1891–1896CrossRefPubMed Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabate MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, Wemeau JL, Caron P, Sadoul JL, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Montanana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A (2007) Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 92:1891–1896CrossRefPubMed
20.
Zurück zum Zitat Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T (2001) Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol 3:152–158PubMed Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T (2001) Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol 3:152–158PubMed
21.
Zurück zum Zitat Dudley KJ, Revill K, Clayton RN, Farrell WE (2009) Pituitary tumours: all silent on the epigenetics front. J Mol Endocrinol 42:461–468CrossRefPubMed Dudley KJ, Revill K, Clayton RN, Farrell WE (2009) Pituitary tumours: all silent on the epigenetics front. J Mol Endocrinol 42:461–468CrossRefPubMed
22.
Zurück zum Zitat Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613–619CrossRefPubMed Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613–619CrossRefPubMed
23.
24.
Zurück zum Zitat Fernandez A, Karavitaki N, Wass JA (2009) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 24 July 2009 [Epub ahead of print] Fernandez A, Karavitaki N, Wass JA (2009) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 24 July 2009 [Epub ahead of print]
25.
Zurück zum Zitat Giacomini D, Paez-Pereda M, Theodoropoulou M, Labeur M, Refojo D, Gerez J, Chervin A, Berner S, Losa M, Buchfelder M, Renner U, Stalla GK, Arzt E (2006) Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology 147:247–256CrossRefPubMed Giacomini D, Paez-Pereda M, Theodoropoulou M, Labeur M, Refojo D, Gerez J, Chervin A, Berner S, Losa M, Buchfelder M, Renner U, Stalla GK, Arzt E (2006) Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology 147:247–256CrossRefPubMed
26.
Zurück zum Zitat Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1608CrossRefPubMed Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1608CrossRefPubMed
27.
Zurück zum Zitat Gulcher J, Stefansson K (1998) Population genomics: laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med 36:523–527CrossRefPubMed Gulcher J, Stefansson K (1998) Population genomics: laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med 36:523–527CrossRefPubMed
28.
Zurück zum Zitat Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S (1999) Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5:1317–1321CrossRefPubMed Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S (1999) Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5:1317–1321CrossRefPubMed
29.
Zurück zum Zitat Hill J (1980) A survey of cancer sites by kinship in the Utah Mormon population. In: Cairns J, Lyon JL, Skolnick M (eds) Banbury Report No 4 Cancer incidence in defined populations. Cold Spring Harbor Laboratory, Cold Spring Harbor Hill J (1980) A survey of cancer sites by kinship in the Utah Mormon population. In: Cairns J, Lyon JL, Skolnick M (eds) Banbury Report No 4 Cancer incidence in defined populations. Cold Spring Harbor Laboratory, Cold Spring Harbor
30.
Zurück zum Zitat Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA (2004) Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation 110:3143–3148CrossRefPubMed Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA (2004) Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation 110:3143–3148CrossRefPubMed
31.
Zurück zum Zitat Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA (2006) Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J 152:305–311CrossRefPubMed Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA (2006) Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J 152:305–311CrossRefPubMed
32.
Zurück zum Zitat Jacoby LB, Hedley-Whyte ET, Pulaski K, Seizinger BR, Martuza RL (1990) Clonal origin of pituitary adenomas. J Neurosurg 73:731–735CrossRefPubMed Jacoby LB, Hedley-Whyte ET, Pulaski K, Seizinger BR, Martuza RL (1990) Clonal origin of pituitary adenomas. J Neurosurg 73:731–735CrossRefPubMed
33.
Zurück zum Zitat Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33:245–254CrossRefPubMed Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33:245–254CrossRefPubMed
34.
Zurück zum Zitat Jonsson H, Manolescu I, Stefansson SE, Ingvarsson T, Jonsson HH, Manolescu A, Gulcher J, Stefansson K (2003) The inheritance of hand osteoarthritis in Iceland. Arthritis Rheum 48:391–395CrossRefPubMed Jonsson H, Manolescu I, Stefansson SE, Ingvarsson T, Jonsson HH, Manolescu A, Gulcher J, Stefansson K (2003) The inheritance of hand osteoarthritis in Iceland. Arthritis Rheum 48:391–395CrossRefPubMed
35.
Zurück zum Zitat Jorde LB (1989) Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices. Ann Hum Genet 53:339–355CrossRefPubMed Jorde LB (1989) Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices. Ann Hum Genet 53:339–355CrossRefPubMed
36.
Zurück zum Zitat Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133:1019–1031CrossRefPubMed Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133:1019–1031CrossRefPubMed
37.
Zurück zum Zitat Lairmore TC, Piersall LD, DeBenedetti MK, Dilley WG, Mutch MG, Whelan AJ, Zehnbauer B (2004) Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg 239:637–645 Discussion 645–637CrossRefPubMed Lairmore TC, Piersall LD, DeBenedetti MK, Dilley WG, Mutch MG, Whelan AJ, Zehnbauer B (2004) Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg 239:637–645 Discussion 645–637CrossRefPubMed
38.
Zurück zum Zitat Malécot G (1948) Les mathématiques de l’hérédité. Masson, Paris Malécot G (1948) Les mathématiques de l’hérédité. Masson, Paris
39.
Zurück zum Zitat Maul JS, Burt RW, Cannon-Albright LA (2007) A familial component to human rectal cancer, independent of colon cancer risk. Clin Gastroenterol Hepatol 5:1080–1084CrossRefPubMed Maul JS, Burt RW, Cannon-Albright LA (2007) A familial component to human rectal cancer, independent of colon cancer risk. Clin Gastroenterol Hepatol 5:1080–1084CrossRefPubMed
40.
Zurück zum Zitat McLellan T, Jorde LB, Skolnick MH (1984) Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 36:836–857PubMed McLellan T, Jorde LB, Skolnick MH (1984) Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 36:836–857PubMed
41.
Zurück zum Zitat Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, Jonsson B (2000) Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 85:1420–1425CrossRefPubMed Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, Jonsson B (2000) Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 85:1420–1425CrossRefPubMed
42.
Zurück zum Zitat Paez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, Grubler Y, Chervin A, Goldberg V, Goya R, Hentges ST, Low MJ, Holsboer F, Stalla GK, Arzt E (2003) Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci USA 100:1034–1039CrossRefPubMed Paez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, Grubler Y, Chervin A, Goldberg V, Goya R, Hentges ST, Low MJ, Holsboer F, Stalla GK, Arzt E (2003) Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci USA 100:1034–1039CrossRefPubMed
43.
Zurück zum Zitat Pei L, Melmed S (1997) Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11:433–441CrossRefPubMed Pei L, Melmed S (1997) Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11:433–441CrossRefPubMed
44.
Zurück zum Zitat Regal M, Paramo C, Sierra SM, Garcia-Mayor RV (2001) Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf) 55:735–740CrossRef Regal M, Paramo C, Sierra SM, Garcia-Mayor RV (2001) Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf) 55:735–740CrossRef
45.
Zurück zum Zitat Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593–602CrossRefPubMed Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593–602CrossRefPubMed
46.
Zurück zum Zitat Skolnick M (1980) The Utah genealogical database: a resource for genetic epidemiology. In: Cairns J, Lyon JL, Skolnick M (eds) Banbury Report No 4 Cancer incidence in defined populations. Cold Spring Harbor Laboratory, Cold Spring Harbor Skolnick M (1980) The Utah genealogical database: a resource for genetic epidemiology. In: Cairns J, Lyon JL, Skolnick M (eds) Banbury Report No 4 Cancer incidence in defined populations. Cold Spring Harbor Laboratory, Cold Spring Harbor
47.
Zurück zum Zitat Sveinbjornsdottir S, Hicks AA, Jonsson T, Petursson H, Gugmundsson G, Frigge ML, Kong A, Gulcher JR, Stefansson K (2000) Familial aggregation of Parkinson’s disease in Iceland. N Engl J Med 343:1765–1770CrossRefPubMed Sveinbjornsdottir S, Hicks AA, Jonsson T, Petursson H, Gugmundsson G, Frigge ML, Kong A, Gulcher JR, Stefansson K (2000) Familial aggregation of Parkinson’s disease in Iceland. N Engl J Med 343:1765–1770CrossRefPubMed
48.
Zurück zum Zitat Tashjian RZ, Farnham JM, Albright FS, Teerlink CC, Cannon-Albright L (2009) Evidence for an inherited predisposition contributing to risk for rotator disease. J Bone Joint Surg 91:1136–1142CrossRefPubMed Tashjian RZ, Farnham JM, Albright FS, Teerlink CC, Cannon-Albright L (2009) Evidence for an inherited predisposition contributing to risk for rotator disease. J Bone Joint Surg 91:1136–1142CrossRefPubMed
49.
Zurück zum Zitat Teerlink CC, Hegewald MJ, Cannon-Albright LA (2007) A genealogical assessment of heritable predisposition to asthma mortality. Am J Respir Crit Care Med 176:865–870CrossRefPubMed Teerlink CC, Hegewald MJ, Cannon-Albright LA (2007) A genealogical assessment of heritable predisposition to asthma mortality. Am J Respir Crit Care Med 176:865–870CrossRefPubMed
50.
Zurück zum Zitat Thomas A, Cannon-Albright L, Bansal A, Skolnick MH (1999) Familial associations between cancer sites. Comput Biomed Res 32:517–529CrossRefPubMed Thomas A, Cannon-Albright L, Bansal A, Skolnick MH (1999) Familial associations between cancer sites. Comput Biomed Res 32:517–529CrossRefPubMed
51.
Zurück zum Zitat Tichomirowa MA, Daly AF, Beckers A (2009) Familial pituitary adenomas. J Intern Med 266:5–18CrossRefPubMed Tichomirowa MA, Daly AF, Beckers A (2009) Familial pituitary adenomas. J Intern Med 266:5–18CrossRefPubMed
52.
Zurück zum Zitat Treier M, Gleiberman AS, O’Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG (1998) Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12:1691–1704CrossRefPubMed Treier M, Gleiberman AS, O’Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG (1998) Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12:1691–1704CrossRefPubMed
53.
Zurück zum Zitat Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De Menis E, Makinen MJ, Launonen V, Karhu A, Aaltonen LA (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312:1228–1230CrossRefPubMed Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De Menis E, Makinen MJ, Launonen V, Karhu A, Aaltonen LA (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312:1228–1230CrossRefPubMed
54.
Zurück zum Zitat Woloschak M, Yu A, Post KD (1997) Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation. Mol Carcinog 19:221–224CrossRefPubMed Woloschak M, Yu A, Post KD (1997) Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation. Mol Carcinog 19:221–224CrossRefPubMed
55.
Zurück zum Zitat Yin Z, Williams-Simons L, Parlow AF, Asa S, Kirschner LS (2008) Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis. Mol Endocrinol 22:380–387CrossRefPubMed Yin Z, Williams-Simons L, Parlow AF, Asa S, Kirschner LS (2008) Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis. Mol Endocrinol 22:380–387CrossRefPubMed
56.
Zurück zum Zitat Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S (1999) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84:761–767CrossRefPubMed Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S (1999) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84:761–767CrossRefPubMed
Metadaten
Titel
A heritable predisposition to pituitary tumors
verfasst von
William T. Couldwell
Lisa Cannon-Albright
Publikationsdatum
01.06.2010
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 2/2010
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-009-0212-0

Weitere Artikel der Ausgabe 2/2010

Pituitary 2/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.